Results 101 to 110 of about 36,760 (309)
Pembrolizumab‐Induced Subacute Cutaneous Lupus Erythematosus: A Case Report
ABSTRACT Subacute cutaneous lupus erythematosus (SCLE) is an increasingly recognized cutaneous immune‐related adverse event of immune checkpoint inhibitors. We report an 83‐year‐old woman who developed pruritic annular and polycyclic plaques 10 weeks after starting pembrolizumab for oropharyngeal squamous cell carcinoma.
Sebastiano Posenato +5 more
wiley +1 more source
Eosinophilic dermatosis of hematologic malignancy.
Cutaneous involvement by an eosinophil-rich process (eosinophilic dermatosis) may be encountered in the setting of various hematologic malignancies, including mantle cell lymphoma, acute monocytic leukemia, acute lymphoblastic leukemia, large cell ...
Sahu, Joya +3 more
core +1 more source
Two Cases of Unilateral Ashy Dermatosis
Ashy dermatosis is a typically asymptomatic disease of unknown origin that causes symmetrical gray spots to appear on the trunk and extremities. We report 2 cases of ashy dermatosis with unilateral distribution.
Koichi Nakagawa +4 more
core +1 more source
Perinevic dermatosis neglecta: clinical and dermoscopic description [PDF]
Perinevic dermatosis neglecta is an underestimated skin condition usually affecting children and adolescents, characterized by the appearance of dirt-like brownish pigmentation around a preexisting nevus and often a matter of concern for parents.
Russo T. +11 more
core +1 more source
Skin samples of Hailey‐Hailey and Darier diseases were analyzed for inflammatory and barrier markers using indirect immunofluorescence and transcriptomic techniques. A mixed Th2/Th17 inflammatory pattern and altered expression of barrier markers were observed.
Ella Glodjajic +10 more
wiley +1 more source
Dermatosis neutrofílicas: revisión [PDF]
Las dermatosis neutrofílicas conforman un grupo de enfermedades que se caracterizan por presentar un infiltrado inflamatorio compuesto por células polimorfonucleares y una patogenia común.
Bertolotti, Mercedes L.
core
Real World Use of the IL‐36 Receptor Antagonist Spesolimab: A Systematic Review and Analysis
ABSTRACT Background Spesolimab, an interleukin‐36 receptor antagonist, is approved for the treatment and prevention of generalised pustular psoriasis (GPP) flares. Its use has increasingly been reported in real‐world settings for both GPP and other inflammatory dermatoses.
Sophia A. Mense +4 more
wiley +1 more source
Pediatric ashy dermatosis: what to expect?
Ashy dermatosis is a pigmentation dermatosis that belongs to the group of acquired macular hyperpigmentation disorders of uncertain etiology. Although the adulthood forms usually occur in higher Fitzpatrick skin types, pediatric cases are more common in ...
Felicidade Santiago +4 more
core
ABSTRACT Ultraviolet‐induced fluorescence dermoscopy (UVFD) is a novel adjunct technique in neoplastic and non‐neoplastic dermatoses. Ochre fluorescence (OF) in dermoscopically suspect lesions has been recently reported to be a strong clue to invasive melanoma. We report the case of a 76‐year‐old male with a multi‐coloured, irregularly shaped pigmented
Marian Voloshynovych +5 more
wiley +1 more source

